Quality of life in monogenic autoinflammatory diseases. A review.


Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
03 2023
Historique:
received: 27 08 2022
revised: 17 10 2022
accepted: 18 10 2022
pubmed: 22 11 2022
medline: 9 3 2023
entrez: 21 11 2022
Statut: ppublish

Résumé

Systemic autoinflammatory diseases (SAIDs) are a group of disorders related to defective regulation of the innate immune system. Recurrence of inflammation can severely affect the patients' outcomes with a direct or indirect impact on their physical and mental health and/or global quality of life (QoL). We therefore sought to identify currently available QoL studies for these diseases as well as measurement tools at our disposal. A systematic literature review was carried out with a focus on monogenic SAIDs. We inventoried the study designs developed in the selected publications, grouped them into similar topics, and listed the different outcome measures used for QoL. We recorded 53 bibliographic references evaluating the impact of monogenic SAIDs on the patients' QoL. These publications revealed 150 different study designs and 82 outcome measures used for their assessment. The best-explored topics were the overall patients' QoL, followed by the evaluation of their psychosocial and physical functioning. We found fair coverage of familial Mediterranean fever, poor investigation of the mixed hereditary recurrent fever (HRF) group, cryopyrin-associated periodic diseases and cherubism, and almost no study of the other monogenic SAIDs. This work revealed areas requiring further investigation such as homogenization of concepts, study of uncommon or more recent diseases, and development of more specific and validated outcome measures for SAIDs.

Sections du résumé

BACKGROUND
Systemic autoinflammatory diseases (SAIDs) are a group of disorders related to defective regulation of the innate immune system. Recurrence of inflammation can severely affect the patients' outcomes with a direct or indirect impact on their physical and mental health and/or global quality of life (QoL). We therefore sought to identify currently available QoL studies for these diseases as well as measurement tools at our disposal.
BASIC PROCEDURES
A systematic literature review was carried out with a focus on monogenic SAIDs. We inventoried the study designs developed in the selected publications, grouped them into similar topics, and listed the different outcome measures used for QoL.
MAIN FINDINGS
We recorded 53 bibliographic references evaluating the impact of monogenic SAIDs on the patients' QoL. These publications revealed 150 different study designs and 82 outcome measures used for their assessment. The best-explored topics were the overall patients' QoL, followed by the evaluation of their psychosocial and physical functioning. We found fair coverage of familial Mediterranean fever, poor investigation of the mixed hereditary recurrent fever (HRF) group, cryopyrin-associated periodic diseases and cherubism, and almost no study of the other monogenic SAIDs.
CONCLUSIONS
This work revealed areas requiring further investigation such as homogenization of concepts, study of uncommon or more recent diseases, and development of more specific and validated outcome measures for SAIDs.

Identifiants

pubmed: 36404572
pii: S1297-319X(22)00135-X
doi: 10.1016/j.jbspin.2022.105475
pii:
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105475

Informations de copyright

Copyright © 2022 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Isabelle Touitou (I)

CeRéMAIA, Department of Genetics, CHU de Montpellier, Inserm, University of Montpellier, A. de Villeneuve Hospital, 371, avenue Doyen-Giraud, Montpellier, France. Electronic address: isabelle.touitou@inserm.fr.

Eric Jéziorski (E)

CeRéMAIA, Department of Genetics, CHU de Montpellier, Inserm, University of Montpellier, A. de Villeneuve Hospital, 371, avenue Doyen-Giraud, Montpellier, France; CeRéMAIA, Department of Pediatrics, CHU de Montpellier, Pediatric Department, Montpellier, France.

Afnan Al-Saleh (A)

CHU de Sainte Justine Research Centre, Department of Pediatrics, CHU de Sainte Justine, University of Montreal, Montreal, QC, Canada.

Aurélia Carbasse (A)

CeRéMAIA, Department of Pediatrics, CHU de Montpellier, Pediatric Department, Montpellier, France.

Maryam Piram (M)

CHU de Sainte Justine Research Centre, Department of Pediatrics, CHU de Sainte Justine, University of Montreal, Montreal, QC, Canada; CeRéMAIA, Department of Pediatric Rheumatology, AP-HP, CHU de Bicêtre, Le Kremlin-Bicêtre, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH